Mapping imported malaria in Bangladesh using parasite genetic and human mobility data
- Harvard T H Chan School of Public Health, United States
- Johns Hopkins Bloomberg School of Public Health, United States
- Mahidol University, Thailand
- Wellcome Sanger Institute, United Kingdom
- Chittagong Medical College, Bangladesh
- Chittagong Medical College Hospital, Bangladesh
- Shaheed Suhrawardy Medical College, Bangladesh
- BRAC Centre, Bangladesh
- National Malaria Elimination Programme, Bangladesh
- World Health Organization, Bangladesh
- Directorate General of Health Services, Bangladesh
- The WorldWide Antimalarial Resistance Network (WWARN), Thailand
- Telenor Group, Norway
- Cited 14
- Views 2,635
- Annotations
Abstract
For countries aiming for malaria elimination, travel of infected individuals between endemic areas undermines local interventions. Quantifying parasite importation has therefore become a priority for national control programs. We analyzed epidemiological surveillance data, travel surveys, parasite genetic data, and anonymized mobile phone data to measure the spatial spread of malaria parasites in southeast Bangladesh. We developed a genetic mixing index to estimate the likelihood of samples being local or imported from parasite genetic data and inferred the direction and intensity of parasite flow between locations using an epidemiological model integrating the travel survey and mobile phone calling data. Our approach indicates that, contrary to dogma, frequent mixing occurs in low transmission regions in the southwest, and elimination will require interventions in addition to reducing imported infections from forested regions. Unlike risk maps generated from clinical case counts alone, therefore, our approach distinguishes areas of frequent importation as well as high transmission.
Article and author information
Author details
Funding
National Institute of General Medical Sciences (U54GM088558)
- Hsiao-Han Chang
Burroughs Wellcome Fund
- Amy Wesolowski
Bill and Melinda Gates Foundation (CPT000390)
- Ipsita Sinha
- Sazid Ibna Zaman
- Richard J Maude
Medical Research Council (G0600718)
- Christopher G Jacob
- Eleanor Drury
- Sonia Gonçalves
- Mihir Kekre
- Dominic Kwiatkowski
National Institute of General Medical Sciences (R35GM124715-02)
- Caroline Buckee
Bill and Melinda Gates Foundation (OPP1118166)
- Christopher G Jacob
- Olivo Miotto
- Caroline Buckee
Bill and Melinda Gates Foundation (OPP1129596)
- Ipsita Sinha
- Sazid Ibna Zaman
- Richard J Maude
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Neil M Ferguson, Imperial College London, United Kingdom
Publication history
- Received: November 9, 2018
- Accepted: March 14, 2019
- Accepted Manuscript published: April 2, 2019 (version 1)
- Version of Record published: April 23, 2019 (version 2)
Copyright
© 2019, Chang et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,635
- Page views
-
- 375
- Downloads
-
- 14
- Citations
Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.
Download links
Downloads (link to download the article as PDF)
Download citations (links to download the citations from this article in formats compatible with various reference manager tools)
Open citations (links to open the citations from this article in various online reference manager services)
Further reading
-
- Epidemiology and Global Health
As of 1 May 2020, there had been 6,808 confirmed cases of COVID-19 in Australia. Of these, 98 had died from the disease. The epidemic had been in decline since mid-March, with 308 cases confirmed nationally since 14 April. This suggests that the collective actions of the Australian public and government authorities in response to COVID-19 were sufficiently early and assiduous to avert a public health crisis — for now. Analysing factors that contribute to individual country experiences of COVID-19, such as the intensity and timing of public health interventions, will assist in the next stage of response planning globally. We describe how the epidemic and public health response unfolded in Australia up to 13 April. We estimate that the effective reproduction number was likely below 1 in each Australian state since mid-March and forecast that clinical demand would remain below capacity thresholds over the forecast period (from mid-to-late April).
-
- Epidemiology and Global Health
- Microbiology and Infectious Disease
Parasitic helminths use two benzoquinones as electron carriers in the electron transport chain. In normoxia they use ubiquinone (UQ), but in the anaerobic conditions inside the host, they require rhodoquinone (RQ) and greatly increase RQ levels. We previously showed the switch from UQ to RQ synthesis is driven by a change in substrates by the polyprenyltransferase COQ-2 (Del Borrello et al., 2019; Roberts Buceta et al., 2019) - how this substrate choice is made is unknown. Here, we show helminths make two coq-2 splice forms, coq-2a and coq-2e, and the coq-2e-specific exon is only found in species that make RQ. We show that in C. elegans COQ-2e is required for efficient RQ synthesis and for survival in cyanide. Crucially, parasites switch from COQ-2a to COQ-2e as they transition into anaerobic environments. We conclude helminths switch from UQ to RQ synthesis principally via changes in the alternative splicing of coq-2.
